Kci Medical India Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 4.00 Cr
as on 23-10-2024
- Company Age 14 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 17.37%
(FY 2023)
- Profit 790.63%
(FY 2023)
- Ebitda 177.38%
(FY 2023)
- Net Worth 42.28%
(FY 2023)
- Total Assets 32.65%
(FY 2023)
About Kci Medical India
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kuppanda Appiah and Inavolu Jagadish serve as directors at the Company.
- CIN/LLPIN
U51397DL2010FTC207599
- Company No.
207599
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
26 Aug 2010
- Date of AGM
24 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Kci Medical India Private Limited offer?
Kci Medical India Private Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Medical Treatment Services.
Who are the key members and board of directors at Kci Medical India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kuppanda Appiah  | Director | 14-Oct-2019 | Current |
| Inavolu Jagadish | Director | 03-Apr-2024 | Current |
Financial Performance and Corporate Structure Insights of Kci Medical India.
Kci Medical India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.37% increase. The company also saw a substantial improvement in profitability, with a 790.63% increase in profit. The company's net worth Soared by an impressive increase of 42.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kci Medical India?
In 2023, Kci Medical India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
3M Electro And Communication India Private LimitedActive 35 years 4 monthsKuppanda Appiah is a mutual person
Trimodal Softech Solutions Private LimitedActive 5 years 11 monthsKuppanda Appiah and Inavolu Jagadish are mutual person
- 3M South Asia Manufacturing Private LimitedActive 12 years 2 months
Kuppanda Appiah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kci Medical India?
Unlock and access historical data on people associated with Kci Medical India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kci Medical India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kci Medical India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
